Visual Hallucinations Due to Rivastigmine Transdermal Patch Application in Alzheimer's Disease; The First Case Report
dc.contributor.author | Değirmenci, Yıldız | |
dc.contributor.author | Keçeci, Hulusi | |
dc.date.accessioned | 2020-04-30T23:46:54Z | |
dc.date.available | 2020-04-30T23:46:54Z | |
dc.date.issued | 2016 | |
dc.department | DÜ, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü | en_US |
dc.description | WOS: 000394271300013 | en_US |
dc.description.abstract | Rivastigmine is a well-known dual acting acetylcholinesterase and butyrylcholinesterase inhibitor, which is effective on behavioral and psychiatric symptoms including hallucinations, as well as cognitive symptoms of dementia. The most common adverse effects of rivastigmine related to cholinergic stimulation in brain and peripheral tissues are gastrointestinal, cardiorespiratory, extrapyramidal, genitourinary, musculoskeletal symptoms, sleep disturbances, and skin irritations with the transdermal patch form in particular. Despite to the previous reports revealing the improving effects of the drug on hallucinations, we presented a-80 year old women with Alzheimer's disease suffering from visual hallucinations whose complaints began with rivastigmine treatment. Since the patient had recent memory disturbance without any behavioral and/or psychiatric symptoms before rivastigmine administration, and visual hallucinations disappeared with the discontinuation of the drug, visual hallucinations were attributed to rivastigmine. Copyright (C) 2016, Taiwan Society of Geriatric Emergency & Critical Care Medicine. Published by Elsevier Taiwan LLC. This is an open access article under the CC BY-NC-ND license. | en_US |
dc.identifier.doi | 10.1016/j.ijge.2015.10.010 | en_US |
dc.identifier.endpage | 241 | en_US |
dc.identifier.issn | 1873-9598 | |
dc.identifier.issn | 1873-958X | |
dc.identifier.issue | 4 | en_US |
dc.identifier.scopusquality | Q4 | en_US |
dc.identifier.startpage | 240 | en_US |
dc.identifier.uri | https://doi.org/10.1016/j.ijge.2015.10.010 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12684/5362 | |
dc.identifier.volume | 10 | en_US |
dc.identifier.wos | WOS:000394271300013 | en_US |
dc.identifier.wosquality | Q4 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.language.iso | en | en_US |
dc.publisher | Elsevier Taiwan | en_US |
dc.relation.ispartof | International Journal Of Gerontology | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.subject | Alzheimer's disease | en_US |
dc.subject | rivastigmine | en_US |
dc.subject | transdermal patch | en_US |
dc.subject | visual hallucinations | en_US |
dc.title | Visual Hallucinations Due to Rivastigmine Transdermal Patch Application in Alzheimer's Disease; The First Case Report | en_US |
dc.type | Article | en_US |
Dosyalar
Orijinal paket
1 - 1 / 1
Yükleniyor...
- İsim:
- 5362.pdf
- Boyut:
- 154.18 KB
- Biçim:
- Adobe Portable Document Format
- Açıklama:
- Tam Metin / Full Text